scPharmaceuticals Inc. SCPH

FDA submission for their pen soon will lead to huge profit opportunities as well as ability to discount and get strong coverage and then sales really will take off!!!

Sales with Nephrologist through the roof, big orders, great quarter!

I did a big dump yesterday at $4.20 but will buy back in the high $3S

Wondering if once the auto injector gets approved, if they will be able to then offer rebates like big Pharma does, and that would lead to better coverage on the plans across the board. From there things skyrocket.

https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-scph/scpharmaceuticals

Price-To-Sales vs Fair Ratio: SCPH is good value based on its Price-To-Sales Ratio (4x) compared to the estimated Fair Price-To-Sales Ratio (5.6x)
 
Significantly Below Fair Value: SCPH is trading below fair value by more than 20%.
 
Future criteria checks 5/6
scPharmaceuticals is forecast to grow earnings and revenue by 67.9% and 34.5% per annum respectively while EPS is expected to grow by 69% per annum.  

Damn, we’re not even back to mid February‘s high yet. I love the back to back days of double digit growth, but come on.

I kind of see this is turning a corner and the shorts exiting realizing this is no longer a safe bet to not succeed. My opinion, we should be well over five dollars based on where we’re at when we’re at $5:50.

I’m sitting here wondering why we are not at least back up to $5.50 here, we have come along way since then, and the growth runway is a lot clearer and evident now.

Some large pharma should buy LXRX and SCPH

Fantastic synergies !!